EG ·
IRBETAN 150MG 10TAB
IRBETAN 150MG 10TAB
Composition
These source-reported data require scientific review and are not treatment advice.
IRBESARTAN
· AMOUNT_PER_UNIT
Registration
Packages and prices
Explainable alternatives
Candidates are informational and are not automatic authorization for substitution or dispensing.
| Product | Match | Differences | Price |
|---|---|---|---|
| IRBEDRIN 75MG 14TAB | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| IRBESARTAN 300MG 7TAB | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| IRBESARTAN 75MG 14TAB | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| XTENSION 300 MG 14 TAB | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| XTENSION 300 MG 28 TAB | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| XTENSION 150 MG 14 TAB | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| APROVAL 150MG 14/TAB | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| IRBEDRIN - DIU 150 12.5 MG 10 TAB | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| X-TENSION PLUS 300/12.5 MG 28 tab | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| X-TENSION 300 MG 28 TAB | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| IRBEDRIN 300 MG 10 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| COAPROVEL 150\12.5 MG 14 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form | — EGP |